Kolexia
Bernadach Maureen Oncologie médicale
Bernadach Maureen
Oncologie médicale
Centre Jean-Perrin
Clermont-Ferrand, France
50 Activités
113 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de la tête et du cou Tumeurs du sein Tumeurs du sein triple-négatives Carcinome épidermoïde Carcinomes Métastase tumorale Récidive tumorale locale Carcinome pulmonaire à petites cellules Tumeurs du poumon

Collaborateurs

Voir plus
Durando Xavier
Durando Xavier
Centre Jean-Perrin, Clermont-Ferrand, France
Herrmann Tressie
Herrmann Tressie
Centre Jean-Perrin, Clermont-Ferrand, France
Masson-Pianetti Morgane
Masson-Pianetti Morgane
Clinique Mutualiste Benigne Joly, Talant, France
Biau Julian
Biau Julian
Centre Jean-Perrin, Clermont-Ferrand, France

Industries

Voir plus
MSD
6 collaboration(s)
Dernière en 2023
Merck-Serono
3 collaboration(s)
Dernière en 2023
Amgen
2 collaboration(s)
Dernière en 2023
Accord Healthcare
2 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
INSTIGO Trial: Evaluation of a Plasma Protein Profile as a Predictive Biomarker for Metastatic Relapse in Triple Negative Breast Cancer Patients
Essai Clinique (Centre Jean-Perrin)   13 février 2024
StrateGlio: Phase III Randomised Trial Evaluating Treatment Intensification With Temozolomide in Adults With a Glioblastoma
Essai Clinique (Centre Oscar-Lambret)   08 février 2024
XenoBreast: A Prospective Study of Xenografts Development From Samples Taken From Surgical Specimens of Patients With Triple Negative or Luminal B Breast Cancer
Essai Clinique (Centre Jean-Perrin)   07 février 2024
The efficacy of immune checkpoint inhibitors following discontinuation for long-term response or toxicity in advanced or metastatic non-small-cell lung cancers: A retrospective study.
Health science reports   25 janvier 2024
NeckTAR: Prediction of Residual Disease by Circulating DNA Detection After Potentiated Radiotherapy for Locally Advanced Head and Neck Cancer
Essai Clinique (Centre Jean-Perrin)   23 janvier 2024
APACAN2: Feasibility Study of an Adapted Physical Activity (APA) for Breast Cancer Patients Treated by Neoadjuvant Chemotherapy and Targeted Therapy Against HER2
Essai Clinique (Centre Jean-Perrin)   21 novembre 2023
Outcomes among oropharyngeal and oral cavity cancer patients treated with postoperative volumetric modulated arctherapy.
Frontiers in oncology   31 octobre 2023
MOIO: Randomized Phase III Trial of Standard Immunotherapy (IO) by Checkpoint Inhibitors, Versus Reduced Dose Intensity of IO in Patients With Metastatic Cancer in Response After 6 Months of Standard IO
Essai Clinique (Unicancer)   29 août 2023
Prediction of residual disease using circulating DNA detection after potentiated radiotherapy for locally advanced head and neck cancer (NeckTAR): a study protocol for a prospective, multicentre trial.
BMC cancer   04 juillet 2023
PERCEPTION Trial Protocol: Comparison of Predictive and Prognostic Capacities of Neutrophil, Lymphocyte and Platelet Counts and Tumour-infiltrating Lymphocytes in Triple Negative Breast Cancer
Essai Clinique (Centre Jean-Perrin)   07 février 2023